Healthcare Services

Global Flowable Hemostats Market: Strategic Growth Insights

April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The Flowable Hemostats Market Grow Between 2026 And 2030?

The market for flowable hemostats has seen robust expansion in recent years. Its valuation is expected to climb from $1.02 billion in 2025 to $1.1 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.8%. The historical increase in this market can be attributed to several factors including a rise in surgical procedure volumes, the increasing adoption of sophisticated surgical tools, the availability of gelatin-based hemostatic agents, the growth of specialty surgical disciplines, and heightened surgeon awareness regarding flowable hemostats.

The flowable hemostats market size is expected to undergo significant expansion in the coming years. It is projected to climb to $1.47 billion by 2030, achieving a compound annual growth rate (CAGR) of 7.5%. This anticipated growth during the forecast period is propelled by factors such as the increasing necessity for faster bleeding control, a heightened focus on patient safety outcomes, the expansion of minimally invasive and robotic surgical techniques, advancements in bioresorbable materials, and their rising utilization in emergency and trauma care settings. Major trends foreseen for this period include the increased application of flowable hemostats in complex surgical procedures, the growing adoption of combination hemostatic products, an increasing demand for rapid hemostasis solutions, the broadening scope of minimally invasive surgical applications, and an enhanced emphasis on biocompatible materials.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/flowable-hemostats-global-market-report

Which Major Drivers Are Influencing The Expansion Of The Flowable Hemostats Market?

The growth of the flowable hemostats market is expected to be propelled by an increasing volume of surgical procedures in the coming period. The rise in surgical procedures is attributed to an aging global population, which in turn boosts the demand for age-related surgeries, as well as technological advancements that have made operations safer and more readily available. Flowable hemostats are highly effective in surgical settings because they assist in controlling bleeding in areas that are difficult to access or where traditional methods may not be sufficient. For instance, in June 2024, a report from the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based professional non-governmental organization, indicated that in 2023, the combined total of surgical and non-surgical procedures grew by 3.4%, reaching 34.9 million, compared to the previous year. Thus, the escalating number of surgical procedures is a primary driver for the expansion of the flowable hemostats market.

How Are Different Segments Classified In The Flowable Hemostats Market Segment Analysis?

The flowable hemostats market covered in this report is segmented –

1) By Product: Active Hemostats, Passive Hemostats, Combination Hemostats

2) By Material: Porcine Gelatin, Bovine Gelatin

3) By Application: General Surgery, Cardiac Surgery, Vascular Surgery, Neuro And Spine Surgery, Orthopedic Surgery, Other Applications

4) By End User: Hospital And Clinics, Ambulatory Surgery Centers

Subsegments:

1) By Active Hemostats: Fibrin Sealants, Thrombin-Based Hemostats, Collagen-Based Hemostats, Biodegradable Polymer Hemostats

2) By Passive Hemostats: Gauze-Based Hemostats, Sponges and Pads, Cellulose-Based Hemostats, Granule-Based Hemostats

3) By Combination Hemostats: Fibrinogen and Thrombin Combination Products, Collagen and Fibrin Combination Products, Synthetic Combination Hemostats, Bioresorbable Combination Hemostats

Which Trends Are Shaping The Flowable Hemostats Market?

Major companies operating in the flowable hemostats market are concentrating on developing surgically advanced hemostatic agents, such as no-swell technology, to address the evolving requirements of surgical procedures. No-swell technology refers to a characteristic of a hemostatic agent that prevents it from absorbing fluids and expanding, making it suitable for utilization in surgeries where swelling could lead to complications. For instance, in January 2023, Medcura Inc., a US-based surgical technology platform, received Food and Drug Administration (FDA) breakthrough device designation for its LifeGel flowable technology, which controls bleeding during surgery for procedures where swelling cannot be tolerated. Medcura’s LifeGel is the initial and only flowable hemostatic gel designed to tackle challenges specific to hemostatic swelling. The absorbable agent does not swell as it is fully hydrated and ready-to-use, potentially mitigating risks associated with swelling, such as nerve injury and paralysis. It is cost-effective, retains antimicrobial properties, is relatively transparent, and mucoadheres to tissues, offering a safer and more effective solution for managing bleeding during complex surgical procedures.

Who Are The Companies Driving Activity In The Flowable Hemostats Market?

Major companies operating in the flowable hemostats market are Pfizer Inc., Johnson & Johnson Services Inc., Medtronic plc, Medline Industries Inc., Stryker Corporation, Baxter International Inc., B Braun Melsungen AG, Becton Dickinson and Company, Cook Medical Inc., Teleflex Incorporated, Mallinckrodt Pharmaceuticals, Integra LifeSciences Holdings Corporation, Gelita Medical GmbH, Ferrosan Medical Devices A/S, Marine Polymer Technologies Inc, Axio Biosolutions Private Limited, Hemostasis LLC, Aegis Lifesciences Private Limited, Medcura Health Inc, Arch Therapeutics Inc., Starch Medical Inc.

Get The Full Flowable Hemostats Market Report:

https://www.thebusinessresearchcompany.com/report/flowable-hemostats-global-market-report

Which Region Represents The Largest Share Of The Flowable Hemostats Market?

North America was the largest region in the flowable hemostats market in 2025. The regions covered in the flowable hemostats market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Flowable Hemostats Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/flowable-hemostats-global-market-report

Browse Through More Reports Similar to the Global Flowable Hemostats Market 2026, By The Business Research Company

Cyclic Heavy Menstrual Bleeding Market Report 2026

https://www.thebusinessresearchcompany.com/report/cyclic-heavy-menstrual-bleeding-global-market-report

Gastrointestinal Bleeding Treatment Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

Bleeding Disorders Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795